Umeworld Stock Price, News & Analysis

UMeWorld Limited (OTC: UMEWF) is a Delaware-based company that focuses on functional nutrition, wellness technologies, and renewable energy applications built on enzymatic processing. According to recent corporate updates, the company operates through a dual platform: its DAGola-branded functional cooking oils and related wellness offerings, and an enzymatic biofuel platform targeting waste-based biodiesel and Sustainable Aviation Fuel (SAF) opportunities. UMeWorld’s shares trade on the OTC Markets under the symbol UMEWF, and operations are centered in Miami, Florida, with Asia-Pacific activities being established in Malaysia.

Business Model and Core Platforms

UMeWorld describes its strategy as a “one technology, two markets” approach. A proprietary enzymatic process underpins both its DAGola™ functional cooking oils and its enzymatic biofuels. In nutrition, the technology is used to produce diacylglycerol (DAG) oils formulated to contain significantly fewer triglycerides than conventional oils and to support improved lipid metabolism. In energy, the same enzymatic know-how is applied to convert low-cost, waste-based feedstocks into low-carbon biodiesel and to enable pathways toward SAF.

On the nutrition side, UMeWorld has built DAGola into its flagship consumer brand. Corporate disclosures describe DAGola as a science-backed cooking oil range with up to 50–80% fewer triglycerides than traditional oils, clinically validated in multiple human trials to support heart health, improve lipid metabolism, and help address metabolic syndrome. The company positions DAGola products for health-conscious consumers, athletes, and individuals focused on weight management and metabolic wellness.

DAGola Functional Cooking Oils and Product Innovation

UMeWorld reports that DAGola oils are produced using a proprietary enzymatic technology that increases DAG content relative to typical edible oils. Company communications state that DAGola oils have been evaluated in clinical studies, including work published in the Journal of Lipid Research and a separate study in overweight adults with elevated blood glucose. These studies reported reductions in triglycerides, uric acid, cholesterol, and body weight under controlled dietary conditions when DAG oil was used as the primary cooking fat.

The DAGola line has expanded into several blends tailored to different culinary and health use cases. Disclosed formulations include:

• DAGola Premium Blend – described as a versatile everyday oil with fewer triglycerides than traditional oils, enriched with vitamin E and omega-3 fatty acids, intended for active individuals and families.
• DAGola Vitality Blend – combining organic MCT oil, Olive DAG oil, and extra virgin olive oil (EVOO), with a specified DAG content and a focus on sustained energy, recovery, and performance.
• DAGola Gourmet Blend – a blend of EVOO and Olive DAG oil aimed at culinary enthusiasts, with a stated reduction in triglycerides compared to conventional oils.
• DAGola Master Chef Blend – combining avocado oil with Olive DAG oil, designed for high-performance kitchens and high-heat applications while offering fewer triglycerides than conventional oils.

UMeWorld reports that DAGola oils are bottled in the United States at a contract manufacturing facility in California, with pilot bottling runs completed for several blends. The company highlights a multi-channel go-to-market strategy that includes direct-to-consumer e-commerce, marketplace distribution, and supplying DAG oil as an ingredient to food manufacturers and private label customers.

Wellness Ecosystem: Supplements and AI-Powered App

Beyond cooking oils, UMeWorld has outlined its evolution into a full-spectrum wellness brand. Company announcements describe an expanded portfolio that includes:

• Cellugizer™ sports nutrition – a supplement line featuring products such as high-protein whey isolate, micronized creatine, and amino acid formulations with electrolytes, aimed at athletes and fitness enthusiasts.
• WellGenix™ – an AI-powered lifestyle app concept designed to provide personalized meal planning, workout optimization, and wellness tracking, with integration to DAGola and Cellugizer products.

UMeWorld presents this wellness ecosystem as a personalized, AI-supported approach to health that targets diverse consumer groups, including athletes, individuals focused on weight management, and broader health-conscious audiences. The company emphasizes a goal of delivering science-backed, customized solutions that address metabolic disorders, cardiovascular disease, obesity, and related conditions through everyday nutrition and lifestyle tools.

Enzymatic Biofuel and SAF Platform

In parallel with its nutrition and wellness activities, UMeWorld is advancing an enzymatic biofuel platform. Corporate updates describe plans for a biofuel pilot and industrial facilities in Malaysia that will process waste-based feedstocks such as palm oil mill effluent (POME), used cooking oil, and animal fats. The company states that its enzymatic process is designed to convert these inputs into sustainable biodiesel and to create intermediates suitable for SAF production.

UMeWorld has outlined a Malaysia-based facility with a planned annual capacity and has reported engagement with an international biofuel engineering group for process design, plant engineering, and project management. It has also identified a general contractor with industrial energy and biofuel experience and is evaluating Malaysian sites based on feedstock availability, logistics, utilities, permitting, and development timelines. The company has indicated an intention to establish a wholly owned subsidiary in Malaysia to operate the pilot facility.

According to company statements, the biofuel platform is engineered to align with EU ReFuelEU Aviation carbon-intensity thresholds, with the goal of positioning its output for eligibility under EU sustainability frameworks. UMeWorld also notes that certification in EU and U.S. markets is a key objective for its enzymatic biofuel, as this would support access to premium markets and potential carbon credit opportunities.

Geographic Footprint and Operations

UMeWorld reports that its operational activities are centered in Miami, Florida, with Asia-Pacific operations being established in Malaysia to support regional management, manufacturing coordination, and growth initiatives. Historically domiciled in the British Virgin Islands, the company has undertaken a statutory merger under which UMeWorld Inc., a Delaware corporation, became the surviving legal entity. Corporate disclosures state that operations are conducted through this Delaware entity, while certain public market references continue to use the name UMeWorld Limited (OTC: UMEWF) pending regulatory processes.

Capital Markets and Governance

UMeWorld has communicated a focus on capital markets readiness. The company has completed a redomiciliation to Delaware through a statutory merger and has engaged investment banking advisors to support a potential uplisting to the NYSE American or Nasdaq, subject to regulatory approvals and market conditions. It highlights this structure as supporting a U.S. reporting framework and aligning with institutional investors focused on environmental, social, and governance (ESG) and energy-transition themes.

An 8-K filing dated January 5, 2026, reports a change in the company’s independent registered public accounting firm due to required audit engagement partner rotation under Public Company Accounting Oversight Board independence rules. The filing notes that the former auditor’s reports for the referenced fiscal years did not contain adverse opinions or disclaimers and that there were no disagreements on accounting principles, financial statement disclosure, or auditing scope or procedure during the relevant periods.

Research, Clinical Validation, and Product Development

UMeWorld emphasizes scientific validation as a core element of its functional nutrition strategy. Company communications reference multiple clinical studies of DAG oil, including:

• A study in overweight adults with elevated blood glucose, in which exclusive use of DAG oil in home cooking was associated with reductions in uric acid, total cholesterol, LDL-C, triglycerides, body weight, and BMI over one to two months.
• A study published in the Journal of Lipid Research focusing on athletes with hyperuricemia, where DAGola oil consumption was associated with improved blood lipid profiles, reduced uric acid, lower triglycerides, reduced oxidative stress, and enhanced metabolic processing of waste products.

To support ongoing innovation, UMeWorld has established a Product Innovation & Development Center and appointed a Chief Scientist with experience in enzymatic science and commercial food innovation. The center’s stated focus is to translate advanced enzymatic research into market-ready functional foods that address metabolic disorders, cardiovascular disease, and obesity.

Strategic Focus and Market Positioning

Across its disclosures, UMeWorld positions itself at the intersection of functional nutrition, personalized wellness, and renewable energy. The company’s strategy highlights:

• Use of enzymatic processing to create DAG-rich cooking oils with reduced triglycerides and clinically supported metabolic benefits.
• Expansion of DAGola as both a branded consumer product line and a B2B ingredient for food manufacturers and private label programs.
• Development of AI-enabled wellness tools and supplement lines to build a broader health and performance ecosystem.
• Application of the same enzymatic technology to waste-based biodiesel and SAF-oriented feedstock processing, with a focus on regulatory alignment and certification.

UMeWorld’s public communications frame this combined approach as a way to address large public health challenges linked to diet and metabolic disease, while also contributing to lower-carbon energy solutions through biofuel and SAF-related projects.

FAQs about UMeWorld Limited (UMEWF)

• What does UMeWorld Limited do?
  UMeWorld Limited, through UMeWorld Inc., focuses on functional nutrition, wellness technologies, and renewable energy applications based on enzymatic processing. Its activities include DAGola-branded functional cooking oils, sports nutrition supplements, AI-supported wellness tools, and an enzymatic biofuel platform targeting waste-based biodiesel and SAF pathways.
• How does UMeWorld’s DAGola oil differ from traditional cooking oils?
  Company disclosures state that DAGola oils are formulated using a proprietary enzymatic process to increase diacylglycerol content and reduce triglycerides compared to conventional oils. Clinical studies cited by UMeWorld report improvements in lipid metabolism and reductions in markers such as triglycerides, uric acid, cholesterol, and body weight under controlled use.
• What is UMeWorld’s biofuel strategy?
  UMeWorld is developing an enzymatic biofuel platform that converts waste-based feedstocks such as palm oil mill effluent, used cooking oil, and animal fats into sustainable biodiesel and SAF-oriented intermediates. The company is planning a facility in Malaysia and aims to align its process with EU and U.S. sustainability and certification frameworks.
• Where is UMeWorld based?
  According to company communications, UMeWorld is a Delaware-based entity with operational activities centered in Miami, Florida. It is also establishing Asia-Pacific operations in Malaysia to support regional management, manufacturing, and growth initiatives.
• What is the significance of UMeWorld’s Delaware redomiciliation?
  UMeWorld reports that it completed a statutory merger under which a Delaware corporation became the surviving entity. The company states that this structure supports a U.S. reporting framework, strengthens corporate governance, and provides a foundation for a potential uplisting to a senior U.S. stock exchange, subject to regulatory approvals and market conditions.
• How is UMeWorld integrating AI into its wellness offerings?
  UMeWorld has announced plans for WellGenix, an AI-powered lifestyle app intended to provide personalized meal planning, workout optimization, and wellness tracking. The app is described as part of a broader effort to deliver tailored, science-backed health solutions connected to DAGola oils and Cellugizer supplements.
• What did UMeWorld report in its January 2026 Form 8-K?
  In a Form 8-K dated January 5, 2026, UMeWorld Inc. reported the resignation of its independent registered public accounting firm due to required audit engagement partner rotation under PCAOB independence rules. The filing states that there were no disagreements on accounting principles, financial statement disclosure, or auditing scope or procedure for the referenced fiscal years.
• Does UMeWorld still trade under the name UMeWorld Limited?
  The company indicates that, although operations are conducted through a Delaware entity, certain corporate actions related to the merger and name changes remain subject to regulatory review. Until that process is completed, public disclosures continue to reference UMeWorld Limited (OTC: UMEWF) for trading and reporting purposes.
• What markets does UMeWorld target for DAGola products?
  UMeWorld’s communications reference activity in the United States, including U.S.-based bottling and e-commerce distribution, and plans or initiatives for markets such as China, Japan, South Korea, Malaysia, and other regions where functional cooking oils and health-focused foods are in demand.
• How does UMeWorld connect its nutrition and energy businesses?
  The company states that a single proprietary enzymatic technology underlies both DAGola functional oils and its enzymatic biofuel platform. This shared technology base allows UMeWorld to pursue opportunities in consumer health and renewable energy using related process expertise.